Top Markets
#1 Black Phoenix Black Phoenix +356.40%
#2 Glidr Glidr +84.34%
#3 Akedo Akedo +59.85%
#4 Gold Park Gold Park +56.34%
#5 Acurast Acurast +37.87%
#6 BasedHype BasedHype +26.41%
#7 OpenEden OpenEden +24.88%
#8 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +22.34%
#9 Cryptopia Cryptopia +21.54%
#10 Quantum Resistant Ledger Quantum Resistant Ledger +15.54%
Coin of the day
Black Phoenix Black Phoenix
Configuración
Idioma
ESPAñOL
Moneda
USD
Tema
Vincerx Pharma, Inc. Vincerx Pharma, Inc.

Vincerx Pharma, Inc.

VINC
Clasificación en acciones #40886
Vincerx Pharma, Inc. is a biopharmaceutical firm currently in the clinical... Vincerx Pharma, Inc. is a biopharmaceutical firm currently in the clinical development phase, dedicated to discovering and advancing innovative treatments for cancer, specifically addressing areas of high medical need within the U.S. Its primary therapeutic asset is VIP152, an inhibitor targeting cyclin-dependent kinase-9 (CDK9), designed for individuals battling advanced forms of cancer. Beyond this lead candidate, the company's pipeline features several preclinical-stage projects: VIP217, an orally administered PTEFb/CDK9 inhibitor; VIP236, a small molecule drug conjugate aimed at solid tumor treatment; and VIP943 and VIP924, both geared towards treating blood cancers. Established in 2019, Vincerx Pharma is based in Palo Alto, California.
Precio por acción
$0.0127
Última sincronización: 2026-08-12
Capitalización bursátil
$66.48K
Cambio (1 día)
-2.31%
Cambio (1 año)
-67.44%
País
US
Comercio Vincerx Pharma, Inc. (VINC)

Categoría

Healthcare
EPS de Vincerx Pharma, Inc. (VINC)
EPS a fecha de 2026 TTM: 0
Según los últimos informes financieros y el precio de las acciones de Vincerx Pharma, Inc., el EPS actual de la empresa (TTM) es 0. Al final del año 2026, la empresa tenía un EPS de 0 igual a al EPS de 2026, que fue de 0.
Historial de EPS de Vincerx Pharma, Inc. desde 2026 hasta 2026
EPS al final de cada año
Año EPS Cambiar
Not enough data for the provided dates.
EPS de empresas similares o competidoras
Empresa EPS Diferencia de EPS País
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $17.32 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $27.74 -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $13.70 -
BE